RE-BVS – Piemonte Repository

Sfoglia per AUTORE
REGE-CAMBRIN G
Collezione AOU San Luigi di Orbassano

Items : 20

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study. in Haematologica / Haematologica. 2022 Oct 1;107(10):2356-2364. doi: 10.3324/haematol.2021.280175.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Soverini S; Albano F; Simula MP; Sorà F; Porretto F; Cavazzini F; Cedrone M; Trabacchi E; Bocchia M; Martino B; Tiribelli M; Rege-Cambrin G; Stagno F; D'Adda M; Salvucci M; Intermesoli T; Levato L; Breccia M; Castagnetti F; Gugliotta G; Foà R; Pane F; Cavo M; Saglio G; Baccarani M; Rosti G;

COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. in British journal of haematology / Br J Haematol. 2022 Feb;196(3):559-565. doi: 10.1111/bjh.17890. Epub 2021 Oct 11.

2022
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Saglio G; Tiribelli M; Foà R; Stagno F; Tafuri A; Sorà F; Sportoletti P; Russo S; Rita Scortechini A; Sancetta R; Rosti G; Rapezzi D; Rege-Cambrin G; Pregno P; Pizzuti M; Cristina Miggiano M; Luzi D; Malato A; Levato L; Loglisci G; Lucchesi A; Luciano L; Lunghi F; Latagliata R; Leonetti Crescenzi S; La Barba G; Intermesoli T; Iurlo A; Gugliotta G; et alii...

Droplet Digital PCR for BCR-ABL1 Monitoring in Diagnostic Routine: Ready to Start? in Cancers / Cancers (Basel). 2021 Oct 30;13(21):5470. doi: 10.3390/cancers13215470.

2021
AOU San Luigi di Orbassano

Bochicchio MT; Petiti J; Berchialla P; Izzo B; Giugliano E; Ottaviani E; Errichiello S; Rege-Cambrin G; Venturi C; Luciano L; Daraio F; Calistri D; Rosti G; Saglio G; Martinelli G; Pane F; Cilloni D; Gottardi EM; Fava C;

Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid Leukemia. in Diseases (Basel, Switzerland) / Diseases. 2021 May 5;9(2):35. doi: 10.3390/diseases9020035.

2021
AOU San Luigi di Orbassano

Fava C; Bernardi S; Gottardi EM; Lorenzatti R; Galeotti L; Ceccherini F; Cordoni F; Daraio F; Giugliano E; Jovanovski A; Petiti J; Varotto M; Barberio D; Rege-Cambrin G; Berchialla P; Sciannameo V; Malagola M; Saglio G; Russo D;

Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts. in Journal of clinical medicine / J Clin Med. 2020 May 13;9(5):1457. doi: 10.3390/jcm9051457.

2020
AOU San Luigi di Orbassano

Petiti J; Lo Iacono M; Dragani M; Pironi L; Fantino C; Rapanotti MC; Quarantelli F; Izzo B; Divona M; Rege-Cambrin G; Saglio G; Gottardi EM; Cilloni D; Fava C;

Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey. in Leukemia / Leukemia. 2020 Aug;34(8):2260-2261. doi: 10.1038/s41375-020-0904-z. Epub 2020 Jun 18.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rosti G; Rege-Cambrin G; Pregno P; Luciano L; Latagliata R; Iurlo A; Gozzini A; Gugliotta G; Galimberti S; Fava C; Castagnetti F; Bonifacio M; Bocchia M; Abruzzese E; Breccia M; Stagno F; Tiribelli M; Foà R; Saglio G; Breccia M; Abruzzese E; Bocchia M; Bonifacio M; Castagnetti F; Fava C; Galimberti S; Gozzini A; Gugliotta G; Iurlo A; et alii...

Pure red cell aplasia and amegakaryocytic thrombocytopenia in thymoma: The uncharted territory. in Clinical case reports / Clin Case Rep. 2020 Mar 17;8(4):598-601. doi: 10.1002/ccr3.2642. eCollection 2020 Apr.

2020
AOU San Luigi di Orbassano

Rege-Cambrin G; Marci V; Familiari U; Andreani G; Dragani M;

Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial. in Frontiers in psychology / Front Psychol. 2019 Feb 20;10:329. doi: 10.3389/fpsyg.2019.00329. eCollection 2019.

2019
AOU San Luigi di Orbassano

Borghi L; Galimberti S; Baratè C; Bonifacio M; Capochiani E; Cuneo A; Falzetti F; Iurlo A; Lunghi F; Minotto C; Orlandi EM; Rege-Cambrin G; Sica S; Supekar S; Haenig J; Vegni E;

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series. in Annals of hematology / Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Baccarani M; Specchia G; Cortelezzi A; Saglio G; Rosti G; Pane F; Bocchia M; Sica S; Breccia M; Luciano L; Martino B; Rege-Cambrin G; Stagno F; Castagnetti F; Gugliotta G; Tiribelli M; Gozzini A; Pungolino E; Bucelli C; Binotto G; Cattaneo D; Fava C; Orlandi EM; Sorà F; Ferrero D; Pregno P; Latagliata R; Annunziata M; Bonifacio M; et alii...

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome. in Oncotarget / Oncotarget. 2016 Nov 29;7(48):80083-80090. doi: 10.18632/oncotarget.11657.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Orlandi EM; Galimberti S; Luciano L; Rege-Cambrin G; Sica S; Sorà F; Calistri E; Isidori A; Crugnola M; Giglio G; Celesti F; Spadea A; Mauro E; Avanzini P; Rossi AR; Cedrone M; Cortesi L; Scaffidi L; D'Addosio AM; Storti S; Gugliotta G; Montefusco E; Falzetti F; Russo S; Mansueto G; Binotto G; Cavazzini F; Annunziata M; Vigneri P; et alii...

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia. in American journal of hematology / Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.

2016
AOU San Luigi di Orbassano

Gugliotta G; Castagnetti F; Breccia M; Gozzini A; Usala E; Carella AM; Rege-Cambrin G; Martino B; Abruzzese E; Albano F; Stagno F; Luciano L; D'Adda M; Bocchia M; Cavazzini F; Tiribelli M; Lunghi M; Pia Falcone A; Musolino C; Levato L; Venturi C; Soverini S; Cavo M; Alimena G; Pane F; Martinelli G; Saglio G; Rosti G; Baccarani M; et alii...

Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S96-S100. doi: 10.1016/j.clml.2016.03.008. Epub 2016 A

2016
AOU San Luigi di Orbassano

Fava C; Rege-Cambrin G; Dogliotti I; Gottardi E; Berchialla P; Di Gioacchino B; Crasto F; Lorenzatti R; Volpengo A; Daraio F; Fantino C; Saglio G;

Update on emerging treatments for chronic myeloid leukemia. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2015 Jun;20(2):183-96. doi: 10.1517/14728214.2015.1031217. Epub 2015 Mar 31

2015
AOU San Luigi di Orbassano

Fava C; Morotti A; Dogliotti I; Saglio G; Rege-Cambrin G;

The choice of first-line chronic myelogenous leukemia treatment. in Annals of hematology / Ann Hematol. 2015 Apr;94 Suppl 2(Suppl 2):S123-31. doi: 10.1007/s00277-015-2321-3. Epub 2015 Mar 27.

2015
AOU San Luigi di Orbassano

Fava C; Rege-Cambrin G; Saglio G;

Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome. in World journal of radiology / World J Radiol. 2014 Aug 28;6(8):583-8. doi: 10.4329/wjr.v6.i8.583.

2014
AOU San Luigi di Orbassano

Cardinale L; Asteggiano F; Moretti F; Torre F; Ulisciani S; Fava C; Rege-Cambrin G;

Chronic myeloid leukemia: state of the art in 2012. in Current oncology reports / Curr Oncol Rep. 2012 Oct;14(5):379-86. doi: 10.1007/s11912-012-0253-9.

2012
AOU San Luigi di Orbassano

Fava C; Rege-Cambrin G; Saglio G;

Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2004 Dec;1028:423-31. doi: 10.1196/annals.1322.050.

2004
AOU San Luigi di Orbassano

Saglio G; Morotti A; Mattioli G; Messa E; Giugliano E; Volpe G; Rege-Cambrin G; Cilloni D;

Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. in Haematologica / Haematologica. 2002 Oct;87(10):1014-20.

2002
AOU San Luigi di Orbassano

Giugliano E; Rege-Cambrin G; Scaravaglio P; Wlodarska I; Emanuel B; Stul M; Serra A; Tonso A; Pini M; Saglio G; Hagemeijer A;

From genes to therapy: the case of Philadelphia chromosome-positive leukemias. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2002 Jun;963:306-12. doi: 10.1111/j.1749-6632.2002.tb04122.x.

2002
AOU San Luigi di Orbassano

Cilloni D; Guerrasio A; Giugliano E; Scaravaglio P; Volpe G; Rege-Cambrin G; Saglio G;

Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation. in Cancer genetics and cytogenetics / Cancer Genet Cytogenet. 2002 Feb;133(1):98-101. doi: 10.1016/s0165-4608(01)00564-7.

2002
AOU San Luigi di Orbassano

Scaravaglio P; Guglielmelli T; Giugliano E; Marmont F; Audisio E; Gallo E; Saglio G; Rege-Cambrin G;